Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$3.5 million.

  • Apyx Medical's Cash from Operations rose 2036.04% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 5146.06%. This contributed to the annual value of -$18.0 million for FY2024, which is 24381.79% down from last year.
  • As of Q3 2025, Apyx Medical's Cash from Operations stood at -$3.5 million, which was up 2036.04% from -$1.2 million recorded in Q2 2025.
  • Apyx Medical's Cash from Operations' 5-year high stood at $3.7 million during Q3 2023, with a 5-year trough of -$6.3 million in Q1 2024.
  • For the 5-year period, Apyx Medical's Cash from Operations averaged around -$3.1 million, with its median value being -$3.6 million (2021).
  • In the last 5 years, Apyx Medical's Cash from Operations crashed by 221682.24% in 2022 and then soared by 16895.52% in 2023.
  • Quarter analysis of 5 years shows Apyx Medical's Cash from Operations stood at $214000.0 in 2021, then plummeted by 2216.82% to -$4.5 million in 2022, then skyrocketed by 51.17% to -$2.2 million in 2023, then plummeted by 32.78% to -$2.9 million in 2024, then fell by 20.39% to -$3.5 million in 2025.
  • Its Cash from Operations stands at -$3.5 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$702000.0 for Q1 2025.